The Pharma Podcast

In this Episode of The Pharma Podcast  we will discuss the financial resources available to Canadian life science companies facing financial hardship in the wake of the COVID-19 Pandemic. 

My guest is Dan Juskovic, Head, Life Sciences and Health Services, RBC.  

Dan offers sound advice  to help  Life Science Companies in Canada who have been directly impacted by COVID-19 and as a result are facing financial challenges.

Dan can be reached by email at: [email protected]

In this episode I spoke with Nathaniel Lipkus, intellectual property litigator, and partner at Osler, Hoskin & Harcourt LLP.

Nate is a legal expert on patent and regulatory issues facing pharmaceutical and biotechnology companies. 

Nate has also published extensively on topics pertaining to Canada’s Patent Act . Nate  recently wrote an article for the Globe and Mail exploring today’s topic.   

In this episode, Nate provides insight on Canada's regulatory framework and how it can assist Canadian access to new therapeutics to the novel coronavirus.  Specifically, we explore the COVID-19 Emergency Response Act (Bill C-13) and its provisions. 

We also explore Canada’s industrial capability to meet future demand to treatment.

CONTACT INFORMATION

[email protected]

This is a special edition of The Pharma Podcast.

Daniel Chiasson, President and CEO of the Canadian Association for Pharmacy Distribution Management (CAPDM), provides his insights on “Canada's Drug Supply Chain and how CAPDM and its members are facing the COVID-19 pandemic.

Jane Farnham is a recognized thought leader in streamlining the complex processes for patients receiving speciality medications. She has both a professional and personal interest in the rare disease space. 

In this episode, Jane will provide insights on “The evolving role of specialty pharmacy in supporting patients with increasingly complex new therapies in a changing regulatory and reimbursement environment.”

Contact Information:
[email protected].

Accelera Canada is Canada’s premier consulting firm offering end to end advice and services to emerging companies wanting to bring their new medical innovation to Canada.  

Deborah Brown is one of Canada's most experienced General Managers with close to three decades  of industry experience -- both domestic and international.

In this episode, Deb will share her insights on how to optimize one's approach to planning a market entry in Canada and the commercial options that emerge from that analysis - and the pitfalls to avoid!

Contact Information:
www.acceleracanada.com
[email protected].

Introduction to the Pharma Podcast - Insights from industry experts and business leaders about important and current topics in Canadian Pharma Biotech and Medtech.

Contact:
[email protected]